Robert Iannone - 06 Jun 2022 Form 4 Insider Report for Jazz Pharmaceuticals plc (JAZZ)

Role
EVP, Global Head of R&D
Signature
By: /s/Adam Guttmann, as attorney in fact For: Robert Iannone
Issuer symbol
JAZZ
Transactions as of
06 Jun 2022
Net transactions value
-$193,279
Form type
4
Filing time
08 Jun 2022, 17:01:43 UTC
Previous filing
09 Mar 2022
Next filing
10 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction JAZZ Ordinary Shares Tax liability $193,279 -1,295 -3.3% $149.25 38,109 06 Jun 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units.
F2 Includes 147 ordinary shares acquired under a Section 423 Employee Stock Purchase Plan on May 31, 2022.